Navigation Links
Thoratec Reports 10 Percent Increase in Fiscal 2007 Revenues; Fourth Quarter Revenues Largest in Company History
Date:2/5/2008

er 2,410 2,773 8,624 8,451

Income before income taxes 2,503 2,250 2,342 2,510

Income tax benefit 1,162 826 893 1,463

Net income $3,665 $3,076 $3,235 $3,973

Net income per share

Basic $0.07 $0.06 $0.06 $0.08

Diluted $0.07 $0.06 $0.06 $0.07

Shares used to compute net income

per share:

Basic 54,062 52,157 53,493 52,155

Diluted 55,220 53,074 54,789 53,270

The following table reconciles the specific items excluded from GAAP net income in the calculation of non-GAAP net income for the periods shown below:

THORATEC CORPORATION

Reconciliation of GAAP to Non-GAAP Net Income

(Unaudited)

(in thousands, except for per share data)

Three Months For the Fiscal

Ended Year Ended

December December December December

29, 2007 31, 2006 29, 2007 31, 2006

Net income on a GAAP basis $3,665 $3,076 $3,235 $3,973

Share-based compensation expense:

- Cost of product sales 405 $12 1,598 1,000

Share-based compensation expense:

- Selling, general and

administrative 2,163 $1,395 7,231 6,120

- Research and development 715 $507 2,585 2,251

Amortization of purchased

intangibles 3,143 $3,134 12,582 12,055

In-process research and development -
'/>"/>

SOURCE Thoratec Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

Related biology technology :

1. Thoratec Presentation at JP Morgan Conference to be Webcast
2. Thoratec Announces Appointment of Steven H. Collis to Board of Directors
3. Thoratec Presentation at Bear Stearns Conference To Be Webcast
4. Thoratec Announces HeartMate II(R) PMA Will be Reviewed by FDA Advisory Panel
5. Rochester Medical Reports 31% Increase in Branded Sales Resulting in 9% Overall Sales Growth for the First Quarter
6. Wyeth Reports Earnings Results for the 2007 Fourth Quarter and Full Year
7. CuraGen Reports Fourth Quarter and Year End 2007 Financial Results
8. Covance Reports Full-Year 2007 Revenue Growth Of 15.4% and Seventh Consecutive Year of EPS Growth in Excess of 20%
9. Phosphagenics Reports Superior Pre-clinical Cholesterol Results from APA-01 and Atorvastatin Combination
10. Viventia Biotech to Explore Strategic Alternatives - Reports Positive Pivotal Phase III Interim Efficacy Data
11. Millennium Biotechnologies Group Reports 40% Sales Increase for Resurgex Product Line in Greek Market
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2014)... PA (PRWEB) July 25, 2014 The ... Call for Topics for Conferee Networking. These two-hour sessions ... interests to meet and resolve problems, discuss new techniques, ... The deadline to submit a topic for consideration is ... pittcon.org . The Conferee Networking committee will review ...
(Date:7/25/2014)... BENSALEM, Pa. , July 25, 2014 /PRNewswire-iReach/ ... services and consulting for global corporations operating in ... will host its first annual Global User Group ... in historic Philadelphia, Pennsylvania ... Photo - http://photos.prnewswire.com/prnh/20140724/130263 ...
(Date:7/24/2014)... NY - July 24, 2014 -- Keryx Biopharmaceuticals, Inc. ... the long-term, randomized, active control Phase 3 study of ... phosphate binder, for the treatment of hyperphosphatemia in patients ... study (PhosphatE binding and iRon delivery with FErric CiTrate ... Journal of the American Society of Nephrology ( ...
(Date:7/24/2014)... , July 24, 2014  Now available is ... home. Rehealth Regenerative Therapies , located in ... other physically active people a new health option: ... Regardless of age, countless patients suffer from joint and ... such as muscle tears, torn rotator cuff, tennis elbow, ...
Breaking Biology Technology:Pittcon 2015 Announces Call for Topics for Conferee Networking Sessions 2Xybion Announces It Will Host International User Conference in Philadelphia 2Xybion Announces It Will Host International User Conference in Philadelphia 3Zerenex (ferric citrate) long-term Phase 3 study results published in JASN 2Zerenex (ferric citrate) long-term Phase 3 study results published in JASN 3Zerenex (ferric citrate) long-term Phase 3 study results published in JASN 4Stem Cells In Sports Injuries, Joints And Muscular Pain 2Stem Cells In Sports Injuries, Joints And Muscular Pain 3
... 19 Over 20 new speakers will,grace the ... &,Business Analysis" conference in two weeks in New ... CI, Business Analysis, and Market,Forecasting executives; 200 from ... to attend the meeting. Competition has never been ...
... Used to Accurately Measure Cardiac Output ... Exercise Testing (CPX), WASHINGTON, September 19 Cheetah Medical ... monitoring, announced at HFSA the results of the study,"Markers of ... The study, led by Dr. Jon Myers of Stanford University ...
... Khosla Ventures, Kleiner Perkins ... TPG Ventures, Strong Endorsement of Technology Pioneer at Forefront of Developing No- ... Compromise ... of renewable hydrocarbon biofuels, today,announced that it closed the first tranche of its ...
Cached Biology Technology:New Competitive Intelligence Speakers Spark Interest in Pharmaceutical Conference on October 1-2 in NJ 2Cheetah Medical's NICOM Non-Invasive Cardiac Output Monitor Featured in a Presentation at the Heart Failure Society of America (HFSA) Annual Meeting 2Cheetah Medical's NICOM Non-Invasive Cardiac Output Monitor Featured in a Presentation at the Heart Failure Society of America (HFSA) Annual Meeting 3Amyris Biotechnologies Announces $70 Million Series B Round 2
(Date:7/28/2014)... by the University of Arizona has sequenced the complete ... enhance scientists, and agriculturalists, understanding of the growing patterns ... of new rice varieties that are better able to ... hunger challenges. , The paper, "The genome sequence of ... independent domestication," was published online in Nature Genetics ...
(Date:7/28/2014)... Medicine have pinpointed a mechanism in part of the brain ... linking it to both type 1 and type 2 diabetes. ... Proceedings of the National Academies of Sciences . ... in a part of the hypothalamus known as the ventromedial ... control glucose levels in the blood," said lead author Sabrina ...
(Date:7/28/2014)... no cure for Alzheimer,s disease and other forms of ... to finding treatment. , University of Washington bioengineers have ... harmful changes of the body,s normal proteins into a ... Parkinson,s, heart disease, Type 2 diabetes and Lou Gehrig,s ... shift from their normal state into an abnormally folded ...
Breaking Biology News(10 mins):Generating a genome to feed the world: UA-led team sequences African rice 2Generating a genome to feed the world: UA-led team sequences African rice 3Generating a genome to feed the world: UA-led team sequences African rice 4Glucose 'control switch' in the brain key to both types of diabetes 2New protein structure could help treat Alzheimer's, related diseases 2New protein structure could help treat Alzheimer's, related diseases 3
... people around the world, causing numerous problems ranging from ... Initial drug use can be motivated by curiosity or ... it can also be the result of a stressful ... study examines the impact of social isolation on the ...
... who studied a little genetics in high school has heard ... C that make up the DNA code. But those are ... past decade has drawn attention to a fifth nucleotide, 5-methylcytosine ... helix to regulate which genes are expressed. And now there,s ...
... time. Travelers in search of answers. It sounds ... it also describes a new approach to teaching earth ... associate professor of geology at Kansas State University, and ... of Missouri at Kansas City, designed TerraWorld, an island ...
Cached Biology News:Early isolation linked to enhanced response to cocaine 2New nucleotide could revolutionize epigenetics 2New nucleotide could revolutionize epigenetics 3New nucleotide could revolutionize epigenetics 4K-State using Second Life island to help high school students learn earth science 2
... GI Number: 4503277 Accession ... Description: FUNCTION: Supplies the nucleotide substrate ... + H 2 O = dUMP ... SIMILARITY: Belongs to the Diseases: Benign ...
Active GST Protein...
All serum is collected from adult animals aged 6 months or older. Certified U.S. orgin. Pricing: $35/unit for 1 - 10 units...
DNA Purification...
Biology Products: